The emerging treatment of this peptide represents a major advance in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide997596.weblogco.com/42319579/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment